[Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].

Sonoo, H; Senoo, T; Nishiki, M; Morimoto, T; Takashima, S

Sonoo, H; Senoo, T; Nishiki, M; Morimoto, T; Takashima, S.

Affiliation

Sonoo H; Dept. of Surgery, Kawasaki Medical School.

Gan To Kagaku Ryoho ; 26(7): 951-8, 1999 Jun.

Article in Ja | MEDLINE | ID: mdl-10396323

Subject(s)

Antineoplastic Agents/administration & dosage; Breast Neoplasms/drug therapy; Floxuridine/administration & dosage; Neoplasm Recurrence, Local/drug therapy; Administration, Oral; Adult; Aged; Antineoplastic Agents/pharmacokinetics; Bone Neoplasms/secondary; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine/pharmacokinetics; Humans; Lymphatic Metastasis; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Floxuridine / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 1999 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links